344 related articles for article (PubMed ID: 34516333)
1. Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis.
Zhong L; Zhong X
Bioengineered; 2021 Dec; 12(1):6629-6642. PubMed ID: 34516333
[TBL] [Abstract][Full Text] [Related]
2. LncRNA DNAJC3-AS1 functions as oncogene in renal cell carcinoma via regulation of the miR-27a-3p/PRDM14 axis.
Na XY; Hu XQ; Zhao Y; Hu CH; Shang XS
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1291-1301. PubMed ID: 33629299
[TBL] [Abstract][Full Text] [Related]
3. The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis.
Zhou Y; Zhang Z; Wo M; Xu W
Bioengineered; 2021 Dec; 12(1):8994-9005. PubMed ID: 34643163
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA ARAP1-AS1 Facilitates the Progression of Cervical Cancer by Regulating miR-149-3p and POU2F2.
Zhou L; Xu XL
Pathobiology; 2021; 88(4):301-312. PubMed ID: 33965958
[TBL] [Abstract][Full Text] [Related]
5. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
[No Abstract] [Full Text] [Related]
6. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
7. The decreased lncRNA ZEB2-AS1 in pre-eclampsia controls the trophoblastic cell line HTR-8/SVneo's invasive and migratory abilities via the miR-149/PGF axis.
Gao Y; Guo X; Li Y; Sha W; She R
J Cell Biochem; 2019 Oct; 120(10):17677-17686. PubMed ID: 31148230
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA ZFPM2-AS1 regulates renal cell carcinoma progression via miR-130a-3p/ESCO2.
Zhang G; Liu SL; Yi WT; Dong YP; Wan YX
Kaohsiung J Med Sci; 2022 Jun; 38(6):530-541. PubMed ID: 35258173
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of SBF2-AS1 functions as a tumor suppressor in clear cell renal cell carcinoma by inhibiting miR-338-3p-targeted ETS1.
Yang X; Zhang Y; Fan H
Cancer Gene Ther; 2021 Aug; 28(7-8):813-827. PubMed ID: 32719443
[TBL] [Abstract][Full Text] [Related]
10. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS.
Jiao M; Guo H; Chen Y; Li L; Zhang L
Biomed Pharmacother; 2020 Aug; 128():110323. PubMed ID: 32526457
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA BRE-AS1 inhibits proliferation, migration and invasion of clear cell renal cell carcinoma by downregulating miR-106b-5p.
Zou G; Guo L; Shen S; Song Z; Ouyang Z; Yu Y
Histol Histopathol; 2024 Jun; 39(6):729-737. PubMed ID: 37530129
[TBL] [Abstract][Full Text] [Related]
12. Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.
Tao M; Zhou Y; Jin Y; Pu J
Pathol Res Pract; 2020 Feb; 216(2):152803. PubMed ID: 31889587
[TBL] [Abstract][Full Text] [Related]
13. LncRNA LINC00667 gets involved in clear cell renal cell carcinoma development and chemoresistance by regulating the miR-143-3p/ZEB1 axis.
Zhao J; Chen P; Tan C; Cheng X; Zhang W; Shen C; Zhang D
Aging (Albany NY); 2023 Oct; 15(19):10057-10071. PubMed ID: 37827696
[TBL] [Abstract][Full Text] [Related]
14. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.
Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B
Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494
[TBL] [Abstract][Full Text] [Related]
15. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
[TBL] [Abstract][Full Text] [Related]
16. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
Yang Y; Dong MH; Hu HM; Min QH; Xiao L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
[TBL] [Abstract][Full Text] [Related]
17. LncRNA ARAP1-AS1 targets miR-516b-5p/PDE5A axis to facilitate the progression of thyroid cancer.
Du Q; Huang L; Guo W
Anticancer Drugs; 2023 Jul; 34(6):735-746. PubMed ID: 36730555
[TBL] [Abstract][Full Text] [Related]
18.
Liu Q; Lei C
Ann Med; 2021 Dec; 53(1):2153-2164. PubMed ID: 34783622
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis.
Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y
Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578
[TBL] [Abstract][Full Text] [Related]
20. A regulatory circuit of lncRNA NLGN1-AS1 and Wnt signalling controls clear cell renal cell carcinoma phenotypes through FZD4-modulated pathways.
Gao H; Chen W; Pan G; Liu H; Qian J; Tang W; Wang W; Qian S
Aging (Albany NY); 2022 Sep; 15(24):15624-15639. PubMed ID: 36170021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]